- Ring The Bell
- Posts
- đȘ Cookie Monster: Google Back Tracks Decision That Will Impact Your Privacy
đȘ Cookie Monster: Google Back Tracks Decision That Will Impact Your Privacy
Google's cookie decision, how experts are trading Tesla's earnings report this afternoon and more
You're receiving this email because you're subscribed to Ring the Bell from Benzinga. To manage your subscription, click the link at the bottom of this email.
Happy Tuesday Zingernation! Itâs election season, itâs earnings season and itâs âholy cow, Iâm going to be on a boat for Labor Day in six weeks and need to lose 10 lbs seasonâ. I havenât quite figured out what to do about the last part yet, but I do know what the experts are saying about Teslaâs upcoming earnings report, which will likely move the entire slew of EV stocks.
âAaron Bry & Nic Chahine
Plus, take a look at the company thatâs using state-of-the-art laser technology to reshape manufacturing industries.
MARKET SNAPSHOT
Yesterday: The S&P 500 notched its best day in more than a month as big tech companies rebounded from last weekâs sell-off. Crowdstrike continued to move lower following Fridayâs widespread outage while other stocks in the space moved higher.
On Our Radar: Hope youâre in the mood for a full serving of earnings because thatâs whatâs for dinner. Tesla, Google, Visa and others are set to report after the bell.
TOP STORY
So: Google decided to abandon its long-standing plan to eliminate cookies in its Chrome browser, citing industry and regulatory pushback.
What Happened: After four years of persistent efforts, delays, and conflicts with the advertising sector, Google made a U-turn on its decision to phase out cookies in Chrome.
Basically: Instead of eliminating cookies, Google will now prompt Chrome users to decide whether to enable or disable cookies, according to the U.K. privacy regulator, which has been overseeing Googleâs cookie-blocking plan. Hereâs how the decision impacts your privacy while browsing the web.
PRESENTED BY LASER PHOTONICS
Laser Photonics Corp. (NASDAQ: LASE) is advancing beyond its renowned lasers for cutting and cleaning, leveraging its R&D to introduce next-gen laser technology and applications.
Notably, its Laser Shield Anti-Drone System (LSAD), developed with Fonon Corporation, aims to neutralize UAVs in conflict zones. Additionally, its CleanTech lasers now offer mobile connectivity, a compact form factor, and smart overheat protection.
Laser Photonics is also launching new laser-cutting systems featuring Turbo Piercing technology to minimize heat-affected zones. Their innovations extend to AI and IoT integrations, driving advancements in the multi-billion-dollar laser industry.
FIVE ZINGERS
The Brown Goes Down: UPS reported earnings this morning, and despite restarting its buyback program, the stock is getting crushed.
Too Much, Too Fast?: Crowdstrike shares fell more than 20% following last weekâs outage. But is the stock poised for a rebound?
How Sweet It Is: Coca-Cola shares edged slightly higher this morning after the beverage giant reported a double beat and said this about demand.
Just Keep Truckinâ: General Motors shares moved higher this morning following the auto manufacturerâs strong earnings report.
The Big Get Bigger?: Microsoft is already the worldâs most valuable company. And analysts are divided on where it will go next.
ONE FOR THE ROAD
Earnings Estimates: Analysts expect Tesla to report second-quarter revenue of $24.93 billion, according to data from Benzinga Pro.
So: Tesla reported revenue of $24.73 billion in last year's second quarter. The company has missed analysts' revenue estimates in three straight quarters.
Basically: Analysts expect the company to report second-quarter earnings per share of 62 cents, compared to 91 cents per share in last year's second quarter. The company has missed analysts' earnings per share estimate in three straight quarters. Here are how some experts are trading the highly-anticipated report, and other stocks that could move on the report.
PRESENTED BY STARPAX
Starpax Biopharma Inc. has officially launched a Regulation A capital raise to finance its clinical trials on humans. The technology is conceived to tackle a major resistance problem for cancer treatments and bring hope to patients and their families worldwide.
Read on to learn more about Starpaxâs revolutionary technology and the opportunity to invest.
Starpax Biopharma is set to address the $901B solid tumor treatment market by creating the cancer treatment of the future with its never-before-seen Precision 3D Guidance Therapy, including Starpax Living MagnetodronesĂŽ and PolarTrakÂź technology.
Starpaxâs technology is set to revolutionize cancer care and improve the lives of patients worldwide. Be part of a mission to create a world where cancer treatment is more effective, safe and accessible.
BEFORE YOU GO
Were you forwarded this email? Click here to subscribe.
And be sure to check out our other newsletters:
Future Finance: Where fintech, crypto, and the future of finance collide. Future Finance is a perfect lunch read packed with quick bites for industry enthusiasts. Subscribe here.
Cannabis Daily: A must-read daily briefing for cannabis investors, operators, and enthusiasts. Join our list of industry veterans to jump start your morning. Subscribe here.
Real Estate Weekly: Where we highlight the movers and the losers, the upgrades and the downgrades, the top stories and opportunities in the trillion dollar REIT and real asset industry. Subscribe here.
Mining Weekly: Get an insider's edge with news, analysis, and commentary on whatâs shaping the mining and commodities industry that powers the global economy. Subscribe here.